Relative antigenicity of allograft components and differential rejection

Transplantation of Composite Tissue Allografts

Volumn , Issue , 2008, Pages 55-69

  Unadkat, Jignesh ^a   Sacks, Justin M ^a   Schneeberger, Stefan ^a   Lee, W P Andrew ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955526482     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-74682-1_6     Document Type: Chapter

References (76)

1. Starzl TE. Back to the future. Transplantation. 2005;79(9):1009-1014.
2. Billingham RE, Medawar PB. Desensitization to skin homografts by injections of donor skin extracts. Ann Surg. 1953;137(4):444-449.
3. Kirk AD. Immunosuppression without immunosuppression? How to be a tolerant individual in a dangerous world. Transpl Infect Dis. 1999;1(1):65-75.
4. Siemionow M, Ozer K. Advances in composite tissue allograft transplantation as related to the hand and upper extremity. J Hand Surg [Am]. 2002;27(4):565-580.
5. Barker JH, Francois CG, Frank JM, Maldonado C. Composite tissue allotransplantation. Transplantation. 2002;73(5):832-835.
6. Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: report on first 6 months. Lancet. 1999;353(9161):1315-1320.
7. Lee WP, Mathes DW. Hand transplantation: pertinent data and future outlook. J Hand Surg [Am]. 1999;24(5):906-913.
8. Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg. 1991;87(3):401-411.
9. Prabhune KA, Gorantla VS, Maldonado C, Perez-Abadia G, Barker JH, Ildstad ST. Mixed allogeneic chimerism and tolerance to composite tissue allografts. Microsurgery. 2000;20(8): 441-447.
10. Buttemeyer R, Jones NF, Min Z, Rao U. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine. Plast Reconstr Surg. 1996;97(1):139- 148; discussion 149-151.
11. Murray JE. Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg. 1971;47(5):425-431.
12. Moseley RV, Sheil AG, Mitchell RM, Murray JE. Immunologic relationships between skin and kidney homografts in dogs on immunosuppressive therapy. Transplantation. 1966;4(6): 678-687.
13. Tanaka S, Sakai A. Stimulation of allogeneic lymphocytes by skin epidermal cells in the rat. Transplantation. 1979;27(3):194-199.
14. Tan CM, Yaremchuk MJ, Randolph MA, Lee WP, Burdick J, Weiland AJ. Vascularized muscle allografts and the role of cyclosporine. Plast Reconstr Surg. 1991;87(3):412-418.
15. Paskert JP, Yaremchuk MJ, Randolph MA, Weiland AJ. The role of cyclosporin in prolonging survival in vascularized bone allografts. Plast Reconstr Surg. 1987;80(2):240-247.
16. Wengerter K, Dardik H. Biological vascular grafts. Semin Vasc Surg. 1999;12(1):46-51.
17. Bain JR, Mackinnon SE, Hudson AR, Falk RE, Falk JA, Hunter DA. The peripheral nerve allograft: an assessment of regeneration across nerve allografts in rats immunosuppressed with cyclosporin A. Plast Reconstr Surg. 1988;82(6):1052-1066.
18. Mackinnon SE, Doolabh VB, Novak CB, Trulock EP. Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg. 2001;107(6):1419-1429.
19. Zhang Z, Zhu L, Quan D, et al. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation. 1996;62(9):1267-1272.
20. Tung TH, Mohanakumar T, Mackinnon SE. TH1/TH2 cytokine profile of the immune response in limb component transplantation. Plast Reconstr Surg. 2005;116(2):557-566.
21. Boyse EA, Old LJ. Loss of skin allograft tolerance by chimeras. Transplantation. 1968;6(4): 619.
22. Kanitakis J, Jullien D, Petruzzo P, et al. Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation. 2003;76(4):688-693.
23. Cendales LC, Kirk AD, Moresi JM, Ruiz P, Kleiner DE. Composite tissue allotransplantation: classification of clinical acute skin rejection. Transplantation. 2006;81(3):418-422.
24. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271-296.
25. Steinmuller D, Wakely E, Landas SK. Evidence that epidermal alloantigen Epa-1 is an immunogen for murine heart as well as skin allograft rejection. Transplantation. 1991;51(2): 459-463.
26. Fuchimoto Y, Gleit ZL, Huang CA, et al. Skin-specific alloantigens in miniature swine. Transplantation. 2001;72(1):122-126.
27. Volc-Platzer B, Majdic O, Knapp W, et al. Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med. 1984;159(6):1784-1789.
28. Dustin ML, Singer KH, Tuck DT, Springer TA. Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1). J Exp Med. 1988;167(4):1323-1340.
29. Simon M Jr., Hunyadi J. Expression of OKM5 antigen on human keratinocytes in positive intracutaneous tests for delayed-type hypersensitivity. Dermatologica. 1987;175(3):121-125.
30. Luger TA, Stadler BM, Katz SI, Oppenheim JJ. Epidermal cell (keratinocyte)-derived thymocyteactivating factor (ETAF). J Immunol. 1981;127(4):1493-1498.
31. Aragane Y, Riemann H, Bhardwaj RS, et al. IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J Immunol. 1994;153(12):5366-5372.
32. Partridge M, Chantry D, Turner M, Feldmann M. Production of interleukin-1 and interleukin-6 by human keratinocytes and squamous cell carcinoma cell lines. J Invest Dermatol. 1991;96(5): 771-776.
33. Barker JN, Jones ML, Mitra RS, et al. Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes. Am J Pathol. 1991;139(4):869-876.
34. Richters CD, van Pelt AM, van Geldrop E, et al. Migration of rat skin dendritic cells. J Leukoc Biol. 1996;60(3):317-322.
35. Nishibu A, Ward BR, Jester JV, Ploegh HL, Boes M, Takashima A. Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli. J Invest Dermatol. 2006; 126(4):787-796.
36. Bergstresser PR, Fletcher CR, Streilein JW. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties. J Invest Dermatol. 1980;74(2): 77-80.
37. Chen HD, Silvers WK. Influence of Langerhans cells on the survival of H-Y incompatible skin grafts in rats. J Invest Dermatol. 1983;81(1):20-23.
38. Kissenpfennig A, Henri S, Dubois B, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 2005;22(5):643-654.
39. Steinmuller D. Passenger leukocytes and the immunogenicity of skin allografts: a critical reevaluation. Transplant Proc. 1981;13(1 Pt 2):1094-1098.
40. Barker CF, Billingham RE. The role of afferent lymphatics in the rejection of skin homografts. J Exp Med. 1968;128(1):197-221.
41. Tyler JD, Steinmuller D. Evidence of cell-mediated cytotoxicity to skin-specific alloantigens on mouse epidermal cells. Transplant Proc. 1981;13(1 Pt 2):1082-1085.
42. Schneeberger S, Kreczy A, Brandacher G, Steurer W, Margreiter R. Steroid- And ATG-resistant rejection after double forearm transplantation responds to Campath-1H. Am J Transplant. 2004;4(8):1372-1374.
43. Karpati G, Pouliot Y, Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol. 1988;23(1):64-72.
44. Hettiaratchy S, Melendy E, Randolph MA, et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation. 2004;77(4): 514-521.
45. Arnoczky SP, Warren RF, Ashlock MA. Replacement of the anterior cruciate ligament using a patellar tendon allograft. An experimental study. J Bone Joint Surg Am. 1986;68(3):376-385.
46. Shino K, Kawasaki T, Hirose H, Gotoh I, Inoue M, Ono K. Replacement of the anterior cruciate ligament by an allogeneic tendon graft. An experimental study in the dog. J Bone Joint Surg Br. 1984;66(5):672-681.
47. Deng W, Zhao H, Dong H. [Clinical application of allogeneic tendon]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2005;19(8):666-668.
48. Zhang Y, Yang K, Zhu W. [Experimental research and clinical application of allogenic tendon grafting]. Zhonghua Wai Ke Za Zhi. 1995;33(9):539-541.
49. Chang Q, Huang X, Guan C. [Treatment of chronic Achilles tendon rupture by use of allogeneic tendon]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2004;18(4):336-337.
50. Guimberteau JC, Baudet J, Panconi B, Boileau R, Potaux L. Human allotransplant of a digital flexion system vascularized on the ulnar pedicle: a preliminary report and 1-year follow-up of two cases. Plast Reconstr Surg. 1992;89(6):1135-1147.
51. Colnot C. Cellular and molecular interactions regulating skeletogenesis. J Cell Biochem. 2005;95(4):688-697.
52. Shaari CM, Farber D, Brandwein MS, Gannon P, Urken ML. Characterizing the antigenic profile of the human trachea: implications for tracheal transplantation. Head Neck. 1998;20(6): 522-527.
53. Burmester GR, Menche D, Merryman P, Klein M, Winchester R. Application of monoclonal antibodies to the characterization of cells eluted from human articular cartilage. Expression of Ia antigens in certain diseases and identification of an 85-kD cell surface molecule accumulated in the pericellular matrix. Arthritis Rheum. 1983;26(10):1187-1195.
54. Donald PJ. Cartilage grafting in facial reconstruction with special consideration of irradiated grafts. Laryngoscope. 1986;96(7):786-807.
55. Langer F, Gross AE. Immunogenicity of allograft articular cartilage. J Bone Joint Surg Am. 1974;56(2):297-304.
56. Whitsett CF, Stulting RD. The distribution of HLA antigens on human corneal tissue. Invest Ophthalmol Vis Sci. 1984;25(5):519-524.
57. Wang EC, Damrose EJ, Mendelsohn AH, et al. Distribution of class I and II human leukocyte antigens in the larynx. Otolaryngol Head Neck Surg. 2006;134(2):280-287.
58. Yang J, Hu J, Wu Z. [Experimental study on the tracheal allografts with decreased antigenicity]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006;20(1):73-76.
59. Burchardt H. The biology of bone graft repair. Clin Orthop Relat Res. 1983(174):28-42.
60. Stevenson S, Li XQ, Martin B. The fate of cancellous and cortical bone after transplantation of fresh and frozen tissue-antigen-matched and mismatched osteochondral allografts in dogs. J Bone Joint Surg Am. 1991;73(8):1143-1156.
61. Friedlaender GE. Immune responses to osteochondral allografts. Current knowledge and future directions. Clin Orthop Relat Res. 1983(174):58-68.
62. Friedlaender GE, Strong DM, Sell KW. Studies on the antigenicity of bone. I. Freeze-dried and deep-frozen bone allografts in rabbits. J Bone Joint Surg Am. 1976;58(6):854-858.
63. Stevenson S. The immune response to osteochondral allografts in dogs. J Bone Joint Surg Am. 1987;69(4):573-582.
64. Goldberg VM, Powell A, Shaffer JW, Zika J, Bos GD, Heiple KG. Bone grafting: role of histocompatibility in transplantation. J Orthop Res. 1985;3(4):389-404.
65. Lee WP, Pan YC, Kesmarky S, et al. Experimental orthotopic transplantation of vascularized skeletal allografts: functional assessment and long-term survival. Plast Reconstr Surg. 1995;95(2):336-349; discussion 350-333.
66. Atchabahian A, Mackinnon SE, Hunter DA. Cold preservation of nerve grafts decreases expression of ICAM-1 and class II MHC antigens. J Reconstr Microsurg. 1999;15(4): 307-311.
67. Ansselin AD, Pollard JD. Immunopathological factors in peripheral nerve allograft rejection: quantification of lymphocyte invasion and major histocompatibility complex expression. J Neurol Sci. 1990;96(1):75-88.
68. Evans PJ, Mackinnon SE, Levi AD, et al. Cold preserved nerve allografts: changes in basement membrane, viability, immunogenicity, and regeneration. Muscle Nerve. 1998;21(11): 1507-1522.
69. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity. 1994;1(9):793-801.
70. Hollenbaugh D, Mischel-Petty N, Edwards CP, et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med. 1995;182(1):33-40.
71. Biedermann BC, Pober JS. Human endothelial cells induce and regulate cytolytic T cell differentiation. J Immunol. 1998;161(9):4679-4687.
72. Briscoe DM, Alexander SI, Lichtman AH. Interactions between T lymphocytes and endothelial cells in allograft rejection. Curr Opin Immunol. 1998;10(5):525-531.
73. Plissonnier D, Nochy D, Poncet P, et al. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation. 1995;60(5):414-424.
74. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, van Es LA, Bruijn JA, van Krieken JH. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet. 2001;357(9249):33-37.
75. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med. 2002;346(1):5-15.
76. Cailhier JF, Laplante P, Hebert MJ. Endothelial apoptosis and chronic transplant vasculopathy: recent results, novel mechanisms. Am J Transplant. 2006;6(2):247-253.